Eni SpA vs Health Care Select Sector SPDR Fund — how do they compare? Eni SpA trades at $48.37 (market cap $70.34B), while Health Care Select Sector SPDR Fund trades at $161.76. The key difference: Eni SpA pays a 4.99% dividend while Health Care Select Sector SPDR Fund pays none, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Eni SpA nearer its low. Which is the better fit depends on your goals.
| E | XLV | |
|---|---|---|
Market Cap | $70.34B | — |
Sector | Energy | — |
52-Week High | $57.61 | $164.48 |
52-Week Low | $32.93 | $129.01 |
Enterprise Value | $89.25B | — |
Dividend Yield | 4.99% | — |
Signals from Pluang's Aura AI — not financial advice
Eni (E) trades at $49.55, up 0.22% with a bullish technical signal supported by moving averages. The company shows stable cash flow generation with $238M net cash flow in 2025 and maintains a dividend of $0.63. Recent strategic expansions into renewable fuels, lithium, and energy trading through partnerships with BMW, Mercuria, and UKAEA highlight diversification efforts. Valuation metrics appear reasonable with P/E of 21.6 and EV/EBITDA of 3.83, though revenue has declined from $132.5B in 2022 to $82.15B in 2025.
The outlook balances strategic growth initiatives against revenue pressures. Opportunities exist in energy transition projects and trading expansion, but risks include oil price volatility and execution challenges. Analyst sentiment is mixed with 34.6% buy ratings versus 61.5% hold, suggesting cautious optimism. The stock's investment case hinges on successful diversification while managing core energy market exposure.
XLV trades at $161.67, up 2.14% with bullish technical momentum supported by moving averages. The healthcare ETF benefits from State Street's upgraded sector outlook and strong performance from holdings like Johnson & Johnson. Technical indicators show mixed signals with oversold RSI_6 but bearish oscillators, while support levels cluster around $156-158.
Outlook remains positive as healthcare gains defensive appeal amid market volatility. Key risks include sector rotation and patent cliff concerns, but institutional rotation into healthcare and innovation trends support long-term growth potential for diversified exposure.
Trailing returns across standard periods
Latest headlines on both assets
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude
Read more on E →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →